APLN and viral infectious disease: Mechanistically, a recent in vitro study demonstrated that apelin-13 inhibits cell-to-cell fusion mediated by ACE2 binding to the S protein; in addition, apelin acts by controlling inflammatory responses to viral infection by inhibiting the nuclear factor kappa B pathway [84].